ZymoGenetics Initiates PEG-Interferon Lambda Phase 2b Clinical Trial In Hepatitis C In Collaboration With Bristol-Myers Squibb

Links shared publicly online about this topic.

  • 1,119
    total visits

ZymoGenetics Initiates PEG-Interferon Lambda Phase 2b Clinical Trial In Hepatitis C In Collaboration With Bristol-Myers Squibb

medicalnewstoday.com —

ZymoGenetics, Inc. (NASDAQ:ZGEN) today announced the initiation of the second part of a Phase 2 clinical trial with PEG-Interferon lambda (IL-29) and ribavirin in treatment-nave patients with ch

View full resource at medicalnewstoday.com

Tags: Liver Condition, Hepatitis, Hepatitis C, Hepatitis C Medication, Phase 2 Clinical Trial, Clinical Trial, Rebetol, Bristol-Myers Squibb

  • Share

Most Recently Shared on June 4, 2010 at 11:07 am By:

mnt_clinical MNT Clinical Trials

ZymoGenetics Initiates PEG-Interferon Lambda Phase 2b Clinical Trial In Hepatitis C In Collaboration With Bristol-Myer... http://mnt.to/3Dvs

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Liver Disease MNT Liver Disease

Advertisement